| Monograph Title
|
Monograph Section
|
Scientific Liaison
|
| ACETAZOLAMIDE ORAL SUSPENSION PF 32(1) Pg. 44
|
Title
|
|
| ACETAZOLAMIDE ORAL SUSPENSION PF 32(1) Pg. 44
|
Definition
|
|
| ACETAZOLAMIDE ORAL SUSPENSION PF 32(1) Pg. 44
|
Packaging and storage
|
|
| ACETAZOLAMIDE ORAL SUSPENSION PF 32(1) Pg. 44
|
Labeling
|
|
| ACETAZOLAMIDE ORAL SUSPENSION PF 32(1) Pg. 44
|
USP Reference standards
|
|
| ACETAZOLAMIDE ORAL SUSPENSION PF 32(1) Pg. 44
|
pH
|
|
| ACETAZOLAMIDE ORAL SUSPENSION PF 32(1) Pg. 44
|
Beyond-use date
|
|
| ACETAZOLAMIDE ORAL SUSPENSION PF 32(1) Pg. 44
|
Assay
|
|
| ALPHA LIPOIC ACID CAPSULES PF 32(6) Pg. 1764
|
Content of alpha lipoic acid
|
|
| ALPRAZOLAM ORAL SUSPENSION PF 32(1) Pg. 46
|
Title
|
|
| ALPRAZOLAM ORAL SUSPENSION PF 32(1) Pg. 46
|
Definition
|
|
| ALPRAZOLAM ORAL SUSPENSION PF 32(1) Pg. 46
|
Packaging and storage
|
|
| ALPRAZOLAM ORAL SUSPENSION PF 32(1) Pg. 46
|
Labeling
|
|
| ALPRAZOLAM ORAL SUSPENSION PF 32(1) Pg. 46
|
USP Reference standards
|
|
| ALPRAZOLAM ORAL SUSPENSION PF 32(1) Pg. 46
|
pH
|
|
| ALPRAZOLAM ORAL SUSPENSION PF 32(1) Pg. 46
|
Beyond-use date
|
|
| ALPRAZOLAM ORAL SUSPENSION PF 32(1) Pg. 46
|
Assay
|
|
| ALPRAZOLAM TABLETS PF 33(1) Pg. 41
|
Assay
|
|
| AZATHIOPRINE ORAL SUSPENSION PF 32(1) Pg. 48
|
Title
|
|
| AZATHIOPRINE ORAL SUSPENSION PF 32(1) Pg. 48
|
Definition
|
|
| AZATHIOPRINE ORAL SUSPENSION PF 32(1) Pg. 48
|
Packaging and storage
|
|
| AZATHIOPRINE ORAL SUSPENSION PF 32(1) Pg. 48
|
Labeling
|
|
| AZATHIOPRINE ORAL SUSPENSION PF 32(1) Pg. 48
|
USP Reference standards
|
|
| AZATHIOPRINE ORAL SUSPENSION PF 32(1) Pg. 48
|
pH
|
|
| AZATHIOPRINE ORAL SUSPENSION PF 32(1) Pg. 48
|
Beyond-use date
|
|
| AZATHIOPRINE ORAL SUSPENSION PF 32(1) Pg. 48
|
Assay
|
|
| BACLOFEN ORAL SUSPENSION PF 32(1) Pg. 51
|
Title
|
|
| BACLOFEN ORAL SUSPENSION PF 32(1) Pg. 51
|
Definition
|
|
| BACLOFEN ORAL SUSPENSION PF 32(1) Pg. 51
|
Packaging and storage
|
|
| BACLOFEN ORAL SUSPENSION PF 32(1) Pg. 51
|
Labeling
|
|
| BACLOFEN ORAL SUSPENSION PF 32(1) Pg. 51
|
USP Reference standards
|
|
| BACLOFEN ORAL SUSPENSION PF 32(1) Pg. 51
|
pH
|
|
| BACLOFEN ORAL SUSPENSION PF 32(1) Pg. 51
|
Beyond-use date
|
|
| BACLOFEN ORAL SUSPENSION PF 32(1) Pg. 51
|
Assay
|
|
| BETHANECHOL CHLORIDE ORAL SOLUTION PF 32(1) Pg. 55
|
Title
|
|
| BETHANECHOL CHLORIDE ORAL SOLUTION PF 32(1) Pg. 55
|
Definition
|
|
| BETHANECHOL CHLORIDE ORAL SOLUTION PF 32(1) Pg. 55
|
Packaging and storage
|
|
| BETHANECHOL CHLORIDE ORAL SOLUTION PF 32(1) Pg. 55
|
Labeling
|
|
| BETHANECHOL CHLORIDE ORAL SOLUTION PF 32(1) Pg. 55
|
USP Reference standards
|
|
| BETHANECHOL CHLORIDE ORAL SOLUTION PF 32(1) Pg. 55
|
pH
|
|
| BETHANECHOL CHLORIDE ORAL SOLUTION PF 32(1) Pg. 55
|
Beyond-use date
|
|
| BETHANECHOL CHLORIDE ORAL SOLUTION PF 32(1) Pg. 55
|
Assay
|
|
| BETHANECHOL CHLORIDE ORAL SUSPENSION PF 32(1) Pg. 57
|
Title
|
|
| BETHANECHOL CHLORIDE ORAL SUSPENSION PF 32(1) Pg. 57
|
Definition
|
|
| BETHANECHOL CHLORIDE ORAL SUSPENSION PF 32(1) Pg. 57
|
Packaging and storage
|
|
| BETHANECHOL CHLORIDE ORAL SUSPENSION PF 32(1) Pg. 57
|
Labeling
|
|
| BETHANECHOL CHLORIDE ORAL SUSPENSION PF 32(1) Pg. 57
|
USP Reference standards
|
|
| BETHANECHOL CHLORIDE ORAL SUSPENSION PF 32(1) Pg. 57
|
pH
|
|
| BETHANECHOL CHLORIDE ORAL SUSPENSION PF 32(1) Pg. 57
|
Beyond-use date
|
|
| BETHANECHOL CHLORIDE ORAL SUSPENSION PF 32(1) Pg. 57
|
Assay
|
|
| BISMUTH SUBSALICYLATE ORAL SUSPENSION PF 31(4) Pg. 1035
|
Packaging and storage
|
|
| BISMUTH SUBSALICYLATE ORAL SUSPENSION PF 33(1) Pg. 41
|
Packaging and storage
|
|
| CALCITONIN SALMON INJECTION PF 30(4) Pg. 1177
|
Title
|
|
| CALCITONIN SALMON INJECTION PF 30(4) Pg. 1177
|
Definition
|
|
| CALCITONIN SALMON INJECTION PF 30(4) Pg. 1177
|
Packaging and storage
|
|
| CALCITONIN SALMON INJECTION PF 30(4) Pg. 1177
|
Labeling
|
|
| CALCITONIN SALMON INJECTION PF 30(4) Pg. 1177
|
USP Reference standards
|
|
| CALCITONIN SALMON INJECTION PF 30(4) Pg. 1177
|
Identification
|
|
| CALCITONIN SALMON INJECTION PF 30(4) Pg. 1177
|
pH
|
|
| CALCITONIN SALMON INJECTION PF 30(4) Pg. 1177
|
Particulate matter
|
|
| CALCITONIN SALMON INJECTION PF 30(4) Pg. 1177
|
Other requirements
|
|
| CALCITONIN SALMON INJECTION PF 30(4) Pg. 1177
|
Assay
|
|
| CALCITONIN SALMON INJECTION PF 30(4) Pg. 1177
|
Bacterial endotoxins
|
|
| CALCITONIN SALMON INJECTION PF 30(4) Pg. 1177
|
Sterility
|
|
| CALCITONIN SALMON NASAL SOLUTION PF 32(3) Pg. 767
|
Title
|
|
| CALCITONIN SALMON NASAL SOLUTION PF 32(3) Pg. 767
|
Definition
|
|
| CALCITONIN SALMON NASAL SOLUTION PF 32(3) Pg. 767
|
Packaging and storage
|
|
| CALCITONIN SALMON NASAL SOLUTION PF 32(3) Pg. 767
|
Labeling
|
|
| CALCITONIN SALMON NASAL SOLUTION PF 32(3) Pg. 767
|
USP Reference standards
|
|
| CALCITONIN SALMON NASAL SOLUTION PF 32(3) Pg. 767
|
Identification
|
|
| CALCITONIN SALMON NASAL SOLUTION PF 32(3) Pg. 767
|
pH
|
|
| CALCITONIN SALMON NASAL SOLUTION PF 32(3) Pg. 767
|
Assay
|
|
| CALCITONIN SALMON NASAL SOLUTION PF 32(3) Pg. 767
|
Microbial limits
|
|
| CALCITONIN SALMON PF 32(3) Pg. 760
|
Title
|
|
| CALCITONIN SALMON PF 32(3) Pg. 760
|
Chemical info
|
|
| CALCITONIN SALMON PF 32(3) Pg. 760
|
Definition
|
|
| CALCITONIN SALMON PF 32(3) Pg. 760
|
Packaging and storage
|
|
| CALCITONIN SALMON PF 32(3) Pg. 760
|
Labeling
|
|
| CALCITONIN SALMON PF 32(3) Pg. 760
|
USP Reference standards
|
|
| CALCITONIN SALMON PF 32(3) Pg. 760
|
Identification
|
|
| CALCITONIN SALMON PF 32(3) Pg. 760
|
Amino acid profile
|
|
| CALCITONIN SALMON PF 32(3) Pg. 760
|
Bioidentity
|
|
| CALCITONIN SALMON PF 32(3) Pg. 760
|
Water, Method Ic
|
|
| CALCITONIN SALMON PF 32(3) Pg. 760
|
Heavy Metals, Method II
|
|
| CALCITONIN SALMON PF 32(3) Pg. 760
|
Acetic acid content
|
|
| CALCITONIN SALMON PF 32(3) Pg. 760
|
Related peptides and other related substances
|
|
| CALCITONIN SALMON PF 32(3) Pg. 760
|
Other requirements
|
|
| CALCITONIN SALMON PF 32(3) Pg. 760
|
Assay
|
|
| CALCITONIN SALMON PF 32(3) Pg. 760
|
Microbial limits
|
|
| CALCITRIOL PF 33(1) Pg. 44
|
Labeling
|
|
| CALCITRIOL PF 33(1) Pg. 44
|
Chemical Info
|
|
| CALCITRIOL PF 33(1) Pg. 44
|
Water, Method Ic <921>
|
|
| CALCITRIOL PF 33(1) Pg. 44
|
Definition
|
|
| CALCITRIOL PF 33(1) Pg. 44
|
Packaging and storage
|
|
| CALCITRIOL PF 33(1) Pg. 44
|
Chromatographic purity
|
|
| CALCITRIOL PF 33(1) Pg. 44
|
Assay
|
|
| CALCIUM GLYCEROPHOSPHATE PF 32(6) Pg. 1765
|
Title
|
|
| CALCIUM GLYCEROPHOSPHATE PF 32(6) Pg. 1765
|
Chemical Info
|
|
| CALCIUM GLYCEROPHOSPHATE PF 32(6) Pg. 1765
|
Definition
|
|
| CALCIUM GLYCEROPHOSPHATE PF 32(6) Pg. 1765
|
Packaging and storage
|
|
| CALCIUM GLYCEROPHOSPHATE PF 32(6) Pg. 1765
|
Appearance of solution
|
|
| CALCIUM GLYCEROPHOSPHATE PF 32(6) Pg. 1765
|
Identification
|
|
| CALCIUM GLYCEROPHOSPHATE PF 32(6) Pg. 1765
|
Acidity or alkalinity
|
|
| CALCIUM GLYCEROPHOSPHATE PF 32(6) Pg. 1765
|
Citric acid
|
|
| CALCIUM GLYCEROPHOSPHATE PF 32(6) Pg. 1765
|
Loss on drying <731>
|
|
| CALCIUM GLYCEROPHOSPHATE PF 32(6) Pg. 1765
|
Glycerol and alcohol-soluble substances
|
|
| CALCIUM GLYCEROPHOSPHATE PF 32(6) Pg. 1765
|
Lead <251>
|
|
| CALCIUM GLYCEROPHOSPHATE PF 32(6) Pg. 1765
|
Iron <241>
|
|
| CALCIUM GLYCEROPHOSPHATE PF 32(6) Pg. 1765
|
Heavy metals, Method I <231>
|
|
| CALCIUM GLYCEROPHOSPHATE PF 32(6) Pg. 1765
|
Limit of chloride
|
|
| CALCIUM GLYCEROPHOSPHATE PF 32(6) Pg. 1765
|
Limit of sulfate
|
|
| CALCIUM GLYCEROPHOSPHATE PF 32(6) Pg. 1765
|
Limit of arsenic
|
|
| CALCIUM GLYCEROPHOSPHATE PF 32(6) Pg. 1765
|
Limit of phosphates
|
|
| CALCIUM GLYCEROPHOSPHATE PF 32(6) Pg. 1765
|
Assay
|
|
| CAPTOPRIL ORAL SOLUTION PF 32(1) Pg. 63
|
Title
|
|
| CAPTOPRIL ORAL SOLUTION PF 32(1) Pg. 63
|
Definition
|
|
| CAPTOPRIL ORAL SOLUTION PF 32(1) Pg. 63
|
Packaging and storage
|
|
| CAPTOPRIL ORAL SOLUTION PF 32(1) Pg. 63
|
Labeling
|
|
| CAPTOPRIL ORAL SOLUTION PF 32(1) Pg. 63
|
USP Reference standards
|
|
| CAPTOPRIL ORAL SOLUTION PF 32(1) Pg. 63
|
pH
|
|
| CAPTOPRIL ORAL SOLUTION PF 32(1) Pg. 63
|
Beyond-use date
|
|
| CAPTOPRIL ORAL SOLUTION PF 32(1) Pg. 63
|
Assay
|
|
| CAPTOPRIL ORAL SUSPENSION PF 32(1) Pg. 64
|
Title
|
|
| CAPTOPRIL ORAL SUSPENSION PF 32(1) Pg. 64
|
Definition
|
|
| CAPTOPRIL ORAL SUSPENSION PF 32(1) Pg. 64
|
Packaging and storage
|
|
| CAPTOPRIL ORAL SUSPENSION PF 32(1) Pg. 64
|
Labeling
|
|
| CAPTOPRIL ORAL SUSPENSION PF 32(1) Pg. 64
|
USP Reference standards
|
|
| CAPTOPRIL ORAL SUSPENSION PF 32(1) Pg. 64
|
pH
|
|
| CAPTOPRIL ORAL SUSPENSION PF 32(1) Pg. 64
|
Beyond-use date
|
|
| CAPTOPRIL ORAL SUSPENSION PF 32(1) Pg. 64
|
Assay
|
|
| CARPROFEN PF 32(6) Pg. 1667
|
Title
|
|
| CARPROFEN PF 32(6) Pg. 1667
|
Chemical Info
|
|
| CARPROFEN PF 32(6) Pg. 1667
|
Definition
|
|
| CARPROFEN PF 32(6) Pg. 1667
|
Packaging and storage
|
|
| CARPROFEN PF 32(6) Pg. 1667
|
Labeling
|
|
| CARPROFEN PF 32(6) Pg. 1667
|
USP Reference standards <11>
|
|
| CARPROFEN PF 32(6) Pg. 1667
|
Identification
|
|
| CARPROFEN PF 32(6) Pg. 1667
|
Loss on drying <731>
|
|
| CARPROFEN PF 32(6) Pg. 1667
|
Residue on ignition <281>
|
|
| CARPROFEN PF 32(6) Pg. 1667
|
Heavy metals, Method II <231>
|
|
| CARPROFEN PF 32(6) Pg. 1667
|
Limit of acetone and methylene chloride
|
|
| CARPROFEN PF 32(6) Pg. 1667
|
Related compounds
|
|
| CARPROFEN PF 32(6) Pg. 1667
|
Assay
|
|
| CARPROFEN TABLETS PF 32(6) Pg. 1669
|
Title
|
|
| CARPROFEN TABLETS PF 32(6) Pg. 1669
|
Definition
|
|
| CARPROFEN TABLETS PF 32(6) Pg. 1669
|
Packaging and storage
|
|
| CARPROFEN TABLETS PF 32(6) Pg. 1669
|
USP Reference standards <11>
|
|
| CARPROFEN TABLETS PF 32(6) Pg. 1669
|
Identification
|
|
| CARPROFEN TABLETS PF 32(6) Pg. 1669
|
Dissolution <711>
|
|
| CARPROFEN TABLETS PF 32(6) Pg. 1669
|
Uniformity of dosage units <905>
|
|
| CARPROFEN TABLETS PF 32(6) Pg. 1669
|
Chromatographic purity
|
|
| CARPROFEN TABLETS PF 32(6) Pg. 1669
|
Assay
|
|
| CITALOPRAM TABLETS PF 33(1) Pg. 46
|
Dissolution <711>
|
|
| CLADRIBINE PF 33(1) Pg. 49
|
Limit of residual solvents
|
|
| CLADRIBINE PF 33(1) Pg. 49
|
Limit of residual Solvent
|
|
| CLONAZEPAM ORAL SUSPENSION PF 32(1) Pg. 73
|
Title
|
|
| CLONAZEPAM ORAL SUSPENSION PF 32(1) Pg. 73
|
Definition
|
|
| CLONAZEPAM ORAL SUSPENSION PF 32(1) Pg. 73
|
Packaging and storage
|
|
| CLONAZEPAM ORAL SUSPENSION PF 32(1) Pg. 73
|
Labeling
|
|
| CLONAZEPAM ORAL SUSPENSION PF 32(1) Pg. 73
|
USP Reference standards
|
|
| CLONAZEPAM ORAL SUSPENSION PF 32(1) Pg. 73
|
pH
|
|
| CLONAZEPAM ORAL SUSPENSION PF 32(1) Pg. 73
|
Beyond-use date
|
|
| CLONAZEPAM ORAL SUSPENSION PF 32(1) Pg. 73
|
Assay
|
|
| CLOPIDOGREL TABLETS PF 33(1) Pg. 50
|
Dissolution <711>
|
|
| CYTARABINE FOR INJECTION PF 33(1) Pg. 51
|
Assay
|
|
